about
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Dr...
Read More
31.91
-0.47
(-1.45%)
552.7K
XNAS Volume
XNAS 09 Sep, 2025 11:48 AM (EDT)
Board Meeting
The latest board meeting for TG Therapeutics Inc took place on 08 Sep 2025, for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
TG Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..